Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214
卡培他滨联合内分泌治疗作为贝伐单抗联合紫杉醇诱导治疗后激素受体阳性、HER2阴性转移性乳腺癌的维持治疗:KBCSG-TR1214
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13174399
Masuda, Norikazu; Yoshinami, Tetsuhiro; Ikeda, Masahiko; Mizutani, Makiko; Yamaguchi, Miki; Komoike, Yoshifumi; Takashima, Tsutomu; Yoshidome, Katsuhide; Tsurutani, Junji; Iwamoto, Mitsuhiko; Fujisawa, Fumie; Yasojima, Hiroyuki; Yamamura, Jun; Morishima, Hirotaka; Aki, Fuminori; Yamada, Tomomi; Morita, Satoshi; Nakayama, Takahiro